Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005;97:115-124
Published online before print June 30, 2005, doi: 10.1161/01.RES.0000175561.55761.69
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
97/2/115    most recent
01.RES.0000175561.55761.69v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kolosova, I. A.
Right arrow Articles by Verin, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kolosova, I. A.
Right arrow Articles by Verin, A. D.
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology
Right arrow Cell signalling/signal transduction
(Circulation Research. 2005;97:115.)
© 2005 American Heart Association, Inc.


Molecular Medicine

Signaling Pathways Involved in Adenosine Triphosphate-Induced Endothelial Cell Barrier Enhancement

Irina A. Kolosova, Tamara Mirzapoiazova, Djanybek Adyshev, Peter Usatyuk, Lewis H. Romer, Jeffrey R. Jacobson, Viswanathan Natarajan, David B. Pearse, Joe G.N. Garcia, Alexander D. Verin

From the Department of Medicine (I.A.K., T.M., D.A., P.U., J.R.J., V.N., D.B.P., J.G.N.G., A.D.V.), Division of Pulmonary and Critical Care Medicine, and Departments of Anesthesiology (L.H.R.), Johns Hopkins University School of Medicine, Baltimore, Md.

Correspondence to Dr Alexander D. Verin, 5200 Eastern Ave, MFL Bldg, Center Tower, Room 660, Baltimore, MD 21224. E-mail averin1{at}jhmi.edu

Endothelial barrier dysfunction caused by inflammatory agonists is a frequent underlying cause of vascular leak and edema. Novel strategies to preserve barrier integrity could have profound clinical impact. Adenosine triphosphate (ATP) released from endothelial cells by shear stress and injury has been shown to protect the endothelial barrier in some settings. We have demonstrated that ATP and its nonhydrolyzed analogues enhanced barrier properties of cultured endothelial cell monolayers and caused remodeling of cell–cell junctions. Increases in cytosolic Ca2+ and Erk activation caused by ATP were irrelevant to barrier enhancement. Experiments using biochemical inhibitors or siRNA indicated that G proteins (specifically G{alpha}q and G{alpha}i2), protein kinase A (PKA), and the PKA substrate vasodilator-stimulated phosphoprotein were involved in ATP-induced barrier enhancement. ATP treatment decreased phosphorylation of myosin light chain and specifically activated myosin-associated phosphatase. Depletion of G{alpha}q with siRNA prevented ATP-induced activation of myosin phosphatase. We conclude that the mechanisms of ATP-induced barrier enhancement are independent of intracellular Ca2+, but involve activation of myosin phosphatase via a novel G-protein–coupled mechanism and PKA.


Key Words: endothelial barrier • extracellular adenosine triphosphate • G protein • myosin phosphatase




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
O. Rentsendorj, T. Mirzapoiazova, D. Adyshev, L. E. Servinsky, T. Renne, A. D. Verin, and D. B. Pearse
Role of vasodilator-stimulated phosphoprotein in cGMP-mediated protection of human pulmonary artery endothelial barrier function
Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L686 - L697.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. A. Kolosova, T. Mirzapoiazova, L. Moreno-Vinasco, S. Sammani, J. G. N. Garcia, and A. D. Verin
Protective effect of purinergic agonist ATP{gamma}S against acute lung injury
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L319 - L324.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Csortos, I. Kolosova, and A. D. Verin
Regulation of vascular endothelial cell barrier function and cytoskeleton structure by protein phosphatases of the PPP family
Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L843 - L854.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
O. C. Colgan, G. Ferguson, N. T. Collins, R. P. Murphy, G. Meade, P. A. Cahill, and P. M. Cummins
Regulation of bovine brain microvascular endothelial tight junction assembly and barrier function by laminar shear stress
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3190 - H3197.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F.V. Hartel, C.W. Rodewald, M. Aslam, D. Gunduz, L. Hafer, J. Neumann, H.M. Piper, and T. Noll
Extracellular ATP induces assembly and activation of the myosin light chain phosphatase complex in endothelial cells
Cardiovasc Res, June 1, 2007; 74(3): 487 - 496.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. R. Jacobson, S. M. Dudek, P. A. Singleton, I. A. Kolosova, A. D. Verin, and J. G. N. Garcia
Endothelial cell barrier enhancement by ATP is mediated by the small GTPase Rac and cortactin.
Am J Physiol Lung Cell Mol Physiol, August 1, 2006; 291(2): L289 - L295.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. Mehta and A. B. Malik
Signaling Mechanisms Regulating Endothelial Permeability
Physiol Rev, January 1, 2006; 86(1): 279 - 367.
[Abstract] [Full Text] [PDF]